期刊导航
期刊开放获取
河南省图书馆
退出
期刊文献
+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息
检索
高级检索
期刊导航
共找到
1
篇文章
<
1
>
每页显示
20
50
100
已选择
0
条
导出题录
引用分析
参考文献
引证文献
统计分析
检索结果
已选文献
显示方式:
文摘
详细
列表
相关度排序
被引量排序
时效性排序
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study
被引量:
3
1
作者
Jian-Qiu WU
Yong-Ping Song
+22 位作者
Li-Ping Su
Ming-Zhi Zhang
Wei Li
Yu Hu
Xiao-Hong Zhang
Yu-Huan Gao
Zuo-Xing Niu
Ru Feng
Wei Wang
Jie-Wen Peng
Xiao-Lin Li
Xue-Nong Ouyang
Chang-Ping Wu
Wei-Jing Zhang
Yun Zeng
Zhen Xiao
Ying-Min Liang
Yong-Zhi Zhuang
Ji-Shi Wang
Zi-Min Sun
Hai Bai
tong-jian cui
Ji-Feng Feng
《Chinese Medical Journal》
SCIE
CAS
CSCD
2018年第15期1767-1775,共9页
关键词
淋巴瘤
治疗
安全
中国
世界
临床
房间
化疗
原文传递
题名
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study
被引量:
3
1
作者
Jian-Qiu WU
Yong-Ping Song
Li-Ping Su
Ming-Zhi Zhang
Wei Li
Yu Hu
Xiao-Hong Zhang
Yu-Huan Gao
Zuo-Xing Niu
Ru Feng
Wei Wang
Jie-Wen Peng
Xiao-Lin Li
Xue-Nong Ouyang
Chang-Ping Wu
Wei-Jing Zhang
Yun Zeng
Zhen Xiao
Ying-Min Liang
Yong-Zhi Zhuang
Ji-Shi Wang
Zi-Min Sun
Hai Bai
tong-jian cui
Ji-Feng Feng
机构
Department of Oncology
Department of Hematology
Department of Hematology
Department of Oncology
Department of Oncology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Oncology
Department of Hematology
Department of Oncology
Department of Oncology
Department of Hematology
Department of Oncology
Department of Oncology
Department of Oncology
TDepartment of Hematology
Department of Hematology
Department of Hematology
Department of Oncology
Department of Hematology
Department of Hematology
Department of Hematology
Department of Oncology
出处
《Chinese Medical Journal》
SCIE
CAS
CSCD
2018年第15期1767-1775,共9页
基金
This study was supported by grants from the National Natural Science Foundation of China (No. 81570186) and the Health and Family Planning Commission of Jiangsu Province (No. H201511).
关键词
淋巴瘤
治疗
安全
中国
世界
临床
房间
化疗
Keywords
Asian
Hematopoietic Malignancy
Hepatitis B Virus
Observational Study
Rituximab
分类号
S896.3 [农业科学—特种经济动物饲养]
TQ658.34 [化学工程—精细化工]
原文传递
题名
作者
出处
发文年
被引量
操作
1
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study
Jian-Qiu WU
Yong-Ping Song
Li-Ping Su
Ming-Zhi Zhang
Wei Li
Yu Hu
Xiao-Hong Zhang
Yu-Huan Gao
Zuo-Xing Niu
Ru Feng
Wei Wang
Jie-Wen Peng
Xiao-Lin Li
Xue-Nong Ouyang
Chang-Ping Wu
Wei-Jing Zhang
Yun Zeng
Zhen Xiao
Ying-Min Liang
Yong-Zhi Zhuang
Ji-Shi Wang
Zi-Min Sun
Hai Bai
tong-jian cui
Ji-Feng Feng
《Chinese Medical Journal》
SCIE
CAS
CSCD
2018
3
原文传递
已选择
0
条
导出题录
引用分析
参考文献
引证文献
统计分析
检索结果
已选文献
上一页
1
下一页
到第
页
确定
用户登录
登录
IP登录
使用帮助
返回顶部